Cancer proteogenomics: current impact and future prospects
Genomic analyses in cancer have been enormously impactful, leading to the identification of
driver mutations and development of targeted therapies. But the functions of the vast majority …
driver mutations and development of targeted therapies. But the functions of the vast majority …
CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2011–2015
QT Ostrom, H Gittleman, G Truitt, A Boscia… - Neuro …, 2018 - academic.oup.com
Background CBTRUS is a unique professional research organization that focuses
exclusively on providing high-quality statistical data on the population-based incidence of …
exclusively on providing high-quality statistical data on the population-based incidence of …
CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2015–2019
Abstract The Central Brain Tumor Registry of the United States (CBTRUS), in collaboration
with the Centers for Disease Control and Prevention and the National Cancer Institute, is the …
with the Centers for Disease Control and Prevention and the National Cancer Institute, is the …
CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2013–2017
Abstract The Central Brain Tumor Registry of the United States (CBTRUS), in collaboration
with the Centers for Disease Control (CDC) and National Cancer Institute (NCI), is the …
with the Centers for Disease Control (CDC) and National Cancer Institute (NCI), is the …
CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2014–2018
Abstract The Central Brain Tumor Registry of the United States (CBTRUS), in collaboration
with the Centers for Disease Control and Prevention (CDC) and National Cancer Institute …
with the Centers for Disease Control and Prevention (CDC) and National Cancer Institute …
Whole genome, transcriptome and methylome profiling enhances actionable target discovery in high-risk pediatric cancer
Abstract The Zero Childhood Cancer Program is a precision medicine program to benefit
children with poor-outcome, rare, relapsed or refractory cancer. Using tumor and germline …
children with poor-outcome, rare, relapsed or refractory cancer. Using tumor and germline …
CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2012–2016
Abstract The Central Brain Tumor Registry of the United States (CBTRUS), in collaboration
with the Centers for Disease Control and Prevention and National Cancer Institute, is the …
with the Centers for Disease Control and Prevention and National Cancer Institute, is the …
[PDF][PDF] Integrated proteogenomic characterization across major histological types of pediatric brain cancer
We report a comprehensive proteogenomics analysis, including whole-genome sequencing,
RNA sequencing, and proteomics and phosphoproteomics profiling, of 218 tumors across 7 …
RNA sequencing, and proteomics and phosphoproteomics profiling, of 218 tumors across 7 …
The chromatin accessibility landscape of primary human cancers
INTRODUCTION Cancer is one of the leading causes of death worldwide. Although the 2%
of the human genome that encodes proteins has been extensively studied, much remains to …
of the human genome that encodes proteins has been extensively studied, much remains to …
Leveraging base-pair mammalian constraint to understand genetic variation and human disease
Thousands of genomic regions have been associated with heritable human diseases, but
attempts to elucidate biological mechanisms are impeded by an inability to discern which …
attempts to elucidate biological mechanisms are impeded by an inability to discern which …